The presence of placenta-derived EVs in maternal circulation have been characterised by the co expression of a placental marker (i.e., placental alkaline phosphatase (PLAP)) [12,14], which has allowed detection of changes in the levels and content of EVs in GDM [11,15,16,17,18]. This evidence concerns the gene ALPP and gestational diabetes.